Literature DB >> 12868041

Effects of short- and long-term detraining on the metabolic response to endurance exercise.

C Petibois1, G Déléris.   

Abstract

Changes in the metabolic response to an endurance exercise were studied (18 rowing km at 75 % of maximal aerobic velocity) during detraining in ten rowers previously highly-trained. Maximal aerobic velocity (VO2 max) and the metabolic response to exercise were determined in the 1 st, 24 th, and 47 th week (training), and in the 52 nd, 76 th, and 99 th week (detraining). Over the decrease of VO2 max, detraining induced a biphasic alteration of the previously observed training adaptations: 1-short-term detraining (5 weeks) resulted in a lower adipose tissue triglyceride (TG) delivery during exercise (p = 0.029), but this one did not represent a direct metabolic limit to exercise since the liver TG delivery increased (p = 0.039), allowing that total fatty acid concentration remained unchanged (12.1 +/- 2.4 vs. 11.8 +/- 2.1 mmol/l; weeks 47 vs. 52); 2-long-term detraining (52 weeks) altered even more the metabolic response to exercise with a decreased total fatty acid concentration during exercise (week 99: 10.6 +/- 2.0 mmol/l; p = 0.022), which induced a higher glycolysis utilization. At this moment, a hemolytic response to endurance exercise was observed through haptoglobin and transferrin concentration changes (weeks 47 vs. 99; p = 0.029 and 0.027, respectively), which resulted probably from higher red blood cell destruction. Endurance-trained athletes should avoid detraining periods over a few weeks since alterations of the metabolic adaptations to training may become rapidly chronic after such delays.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12868041     DOI: 10.1055/s-2003-40708

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  8 in total

1.  ACL Research Retreat V: an update on ACL injury risk and prevention, March 25-27, 2010, Greensboro, NC.

Authors:  Sandra J Shultz; Randy J Schmitz; Anh-Dung Nguyen; Ajit M Chaudhari; Darin A Padua; Scott G McLean; Susan M Sigward
Journal:  J Athl Train       Date:  2010 Sep-Oct       Impact factor: 2.860

2.  Risk factor screening and prevention.

Authors: 
Journal:  J Athl Train       Date:  2008 Sep-Oct       Impact factor: 2.860

3.  Effects of a 12-Week Detraining Period on Physical Capacity, Power and Speed in Elite Swimmers.

Authors:  Wojciech Głyk; Maciej Hołub; Jakub Karpiński; Wojciech Rejdych; Wojciech Sadowski; Alina Trybus; Jakub Baron; Łukasz Rydzik; Tadeusz Ambroży; Arkadiusz Stanula
Journal:  Int J Environ Res Public Health       Date:  2022-04-11       Impact factor: 4.614

Review 4.  Physiological changes associated with the pre-event taper in athletes.

Authors:  Iñigo Mujika; Sabino Padilla; David Pyne; Thierry Busso
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

5.  Post-season detraining effects on physiological and performance parameters in top-level kayakers: comparison of two recovery strategies.

Authors:  Jesús García-Pallarés; Luis Carrasco; Arturo Díaz; Luis Sánchez-Medina
Journal:  J Sports Sci Med       Date:  2009-12-01       Impact factor: 2.988

6.  Identification of serum analytes and metabolites associated with aerobic capacity.

Authors:  Michael S Lustgarten; Lori Lyn Price; Tanya Logvinenko; Christos Hatzis; Nandan Padukone; Nicholas V Reo; Edward M Phillips; Dylan Kirn; John Mills; Roger A Fielding
Journal:  Eur J Appl Physiol       Date:  2012-11-27       Impact factor: 3.078

Review 7.  The COVID-19 Pandemic Lowers Active Behavior of Patients with Cardiovascular Diseases, Healthy Peoples and Athletes.

Authors:  Marine Kirsch; Damien Vitiello
Journal:  Int J Environ Res Public Health       Date:  2022-01-19       Impact factor: 4.614

8.  Effects of Short- and Long-Term Detraining on Maximal Oxygen Uptake in Athletes: A Systematic Review and Meta-Analysis.

Authors:  Jie Zheng; Tian Pan; Yankang Jiang; Yupeng Shen
Journal:  Biomed Res Int       Date:  2022-08-16       Impact factor: 3.246

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.